Saint Luke's Newsroom
Apr. 15, 2022
KCTV: Saint Luke's Health System Participates in SevenDays of Kindness Movement
KCTV talked to Nikki Beard about what Saint Luke's is doing to encourage cultural humility and kindness.
Apr. 14, 2022
Blue Valley Post: With COVID Cases Down, JoCo ERs Prep for More Typical Summer Issue: Outdoor Injuries
The Blue Valley Post talked to Dr. Chris Bowser about trends local emergency departments see over the warmer months and how to avoid becoming part of the trend.
Apr. 14, 2022
HealthDay: Empagliflozin Offers Clinical Benefit in Heart Failure
A new study by Dr. Kosiborod and colleagues found clinical benefits in treatment with empagliflozin for patients hospitalized with acute heart failure.
Apr. 13, 2022
KCTV: Donate Life Month: Organ Donation Myths Busted
In honor of Donate Life Month, KCTV talked to Dr. Lee Cummings to bust some common misconceptions about organ donation.
Apr. 13, 2022
FOX4: Northeast Middle School Stabbing: Student Critically Injured
A middle school student was critically injured in a stabbing at Northeast Middle School. 
Apr. 8, 2022
KMBC: Books & Boutiques Event Raises Funds for Cardiovascular Program at Saint Luke's South Hospital
Acclaimed Kansas author Sarah Smarsh spoke about her book for the annual Books & Boutiques event, benefitting Saint Luke's South Hospital.
Apr. 8, 2022
TCTMD: Quality of Life Gains Within 15 Days in Acute Heart Failure with Empagliflozin: EMPULSE Analysis
A secondary analysis of the EMPULSE trial provides more context to the quality-of-life benefits of the early initiation of empagliflozin in patients hospitalized with acute decompensated heart failure.
Apr. 8, 2022
Healio: Empagliflozin Benefits Acute HF Regardless of Baseline Impairment: EMPULSE
Study shows patients with acute heart failure assigned the SGLT2 inhibitor empagliflozin saw a greater improvement in HF symptoms, physical limitations and quality of life measures vs. placebo.
Apr. 6, 2022
Chillicothe Constitution-Tribune: Finding Strength Within
The Chillicothe Constitution-Tribune talked to Dr. Todd Moore and colon cancer survivor Johanne Blackburn about the importance of regular screenings.